India to Singapore: Cladribine Export Trade Route

The India to Singapore Cladribine corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $20.0K USD. The route is dominated by GNH INDIA PHARMACEUTICALS LIMITED , which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's cladribine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with cladribine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 13.4%, placing it at rank #15 among India's top cladribine export destinations globally.

On the import side, key buyers of Indian cladribine in Singapore include SHIYUN , TO THE IMPORT MANAGER CLIENT CODE, TO THE ORDER and 4 others. SHIYUN is the single largest importer with 3 shipments valued at $7.2K USD.

India's cladribine exports to Singapore are driven primarily by a handful of large-scale manufacturers. GNH INDIA PHARMACEUTICALS LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Singapore benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GNH INDIA PHARMACEUTICALS LIMITED , KINGS GLOBAL BIOTECH LIMITED, GNH India Pharmaceuticals Limited — together account for 86% of total trade value on this route. The average shipment value of $1.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products for human use b n 87240353aa mfg 09 24 exp 08 26 cladribine cladrim 10mg 10ml injecti and pharmaceutical products for humanuse b n 87240353aa mfg 09 24 exp 08 26 cladribine cladrim 10mg 10ml inject, suggesting that buyers in Singapore tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SHIYUN is the largest importer with 3 shipments worth $7.2K USD — representing 36% of all cladribine imports from India on this route. A total of 7 buyers are active on this corridor.